1. Home
  2. MPB vs HUMA Comparison

MPB vs HUMA Comparison

Compare MPB & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mid Penn Bancorp

MPB

Mid Penn Bancorp

HOLD

Current Price

$36.09

Market Cap

827.5M

Sector

Finance

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

N/A

Current Price

$0.54

Market Cap

165.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MPB
HUMA
Founded
1868
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
827.5M
165.7M
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
MPB
HUMA
Price
$36.09
$0.54
Analyst Decision
Buy
Strong Buy
Analyst Count
1
8
Target Price
★ $37.00
$6.19
AVG Volume (30 Days)
71.5K
★ 4.2M
Earning Date
04-21-2026
05-15-2026
Dividend Yield
★ 2.66%
N/A
EPS Growth
N/A
★ 79.37
EPS
★ 1.22
N/A
Revenue
N/A
★ $2,038,000.00
Revenue This Year
$30.95
$444.16
Revenue Next Year
$9.45
$248.39
P/E Ratio
$29.79
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.56
$0.53
52 Week High
$39.15
$2.55

Technical Indicators

Market Signals
Indicator
MPB
HUMA
Relative Strength Index (RSI) 40.00 36.71
Support Level $35.87 N/A
Resistance Level $37.46 $0.61
Average True Range (ATR) 0.69 0.03
MACD -0.09 0.00
Stochastic Oscillator 15.69 2.44

Price Performance

Historical Comparison
MPB
HUMA

About MPB Mid Penn Bancorp

Mid Penn Bancorp Inc is a financial holding company, providing various banking and financial products and services through its subsidiaries. These products and services mainly include consumer banking products, including secure checking and savings accounts, mobile banking, agricultural loans, construction financing, mortgages, home equity loans and lines of credit, credit cards, and more. Additionally, the Group offers trust services, insurance products, wealth management, and private banking services. The Group caters to individuals, partnerships, non-profit organizations, and corporations through its retail banking offices located throughout Pennsylvania, with a minor portion in New Jersey.

About HUMA Humacyte Inc.

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: